Cyterix Pharmaceuticals' Unattributed VC Round

Cyterix Pharmaceuticals raised a round of funding on February 25, 2011.

Cyterix Pharmaceuticals is developing tumor selective cytochrome P450 activated prodrugs.…

Articles about Cyterix Pharmaceuticals' Unattributed VC Round: